Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-03
2006-10-03
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S394000, C514S230500, C514S310000, C514S248000, C548S335500, C548S309700, C548S343500, C544S063000, C544S237000, C546S139000
Reexamination Certificate
active
07115646
ABSTRACT:
The present application describes cyclic diamino compounds, derivatives thereof, and pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.
REFERENCES:
patent: 6472386 (2002-10-01), Kodama et al.
patent: 6632810 (2003-10-01), Kodama et al.
patent: 6686353 (2004-02-01), Shiota et al.
patent: 2005/0119486 (2005-06-01), Ohta et al.
patent: 2005/0245565 (2005-11-01), Ohta et al.
patent: 2004/0172063 (2001-10-01), None
patent: 2004/0119486 (2003-01-01), None
patent: 2005/0245565 (2003-01-01), None
patent: WO 03/045912 (2003-06-01), None
Bristol Myers Squibb Co.
Grazier Nyeemah
Saeed Kamal A.
Sun Jing G.
Vance David H.
LandOfFree
Cyclic diamines and derivatives as factor Xa inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic diamines and derivatives as factor Xa inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic diamines and derivatives as factor Xa inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3669184